0001673510-19-000001.txt : 20190123 0001673510-19-000001.hdr.sgml : 20190123 20190123105116 ACCESSION NUMBER: 0001673510-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190123 DATE AS OF CHANGE: 20190123 EFFECTIVENESS DATE: 20190123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alcresta Therapeutics, Inc. CENTRAL INDEX KEY: 0001673510 IRS NUMBER: 452729951 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-331139 FILM NUMBER: 19536748 BUSINESS ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD STREET 2: 4TH FLOOR CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 617 431 3600 MAIL ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD STREET 2: 4TH FLOOR CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Alcresta, Inc. DATE OF NAME CHANGE: 20160502 D 1 primary_doc.xml X0708 D LIVE 0001673510 Alcresta Therapeutics, Inc. 15 INDEPENDENCE BOULEVARD 4TH FLOOR WARREN NJ NEW JERSEY 07059 617 431 3600 DELAWARE Alcresta, Inc. Corporation true Anastasios Konidaris 15 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 Executive Officer Director Steve Dubin 15 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 Director Stephen Kraus 15 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 Director Garheng Kong 15 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 Director Alexey Margolin 15 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 Director William Scheinler 15 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 Executive Officer Biotechnology Decline to Disclose 06b false 2019-01-14 false true false 0 25000000 5000008 19999992 false 19 0 0 0 false Alcresta Therapeutics, Inc. /s/ Anastasios Konidaris Anastasios Konidaris Chief Financial Officer 2019-01-22